로딩 중…
지수 로딩 중…
Vivozon Pharmaceutical Co., Ltd.
082800· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩3,140-3.38%
2026-06-19
Price Chart
Vivozon Pharmaceutical Co., Ltd.-50.01%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 190.66B KRW |
| Revenue | 54.86B KRW |
| Net Income | -34.21B KRW |
| Total Assets | 170.75B KRW |
| Net Assets | 97.74B KRW |
| Employees | 394 |
| Value | |
| P/B | 1.95x |
| P/S | 3.48x |
| FCF Yield | -3.60% |
| Profitability | |
| ROE | -35.00% |
| ROA | -20.04% |
| Op. Margin | -35.87% |
| Revenue Growth | -24.10% |
| Financial Health | |
| Debt Ratio | 174.70% |
| Total Debt | 35.08B KRW |
| FCF | -6.87B KRW |
| Cash | 14.19B KRW |
| Current Ratio | 0.71x |
| Performance | |
| 1Y Return | -50.01% |
| 1M Return | 18.27% |
| From 52W High | -62.45% |
| 1Y MDD | -72.02% |
| Trading | |
| Volume | 658,492 shares |
| Foreign Own. | 1.10% |
| Per Share | |
| EPS | -636 KRW |
| BPS | 1,624 KRW |
Company Info
VIVAZON Pharm, established in 2002 and listed on KOSDAQ in 2005, is a finished pharmaceutical product manufacturing and sales company. It possesses over 190 items, including cardiovascular drugs, dermatological external preparations, and antipyretic analgesics and anti-inflammatory drugs, engaging in ETC, OTC, CMO, OEM businesses, and overseas exports. The company's pharmaceutical research institute focuses on developing generics, combination drugs, formulation changes, and differentiated products using controlled-release technology. VIVAZON Pharm is headquartered in Hwaseong-si, Gyeonggi-do.